Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Sign Up
PubMed This is a summary of 31 peer-reviewed journal articles Updated
Urology · Benign Prostatic Hyperplasia

How Is Recurrent Urinary Retention From BPH Treated?

At a Glance

Recurrent urinary retention from BPH usually needs catheter drainage and urologic assessment. Medicines may help some people urinate after catheter removal, but repeated episodes often lead to TURP or HoLEP to relieve the prostate blockage; a weak bladder may still require a catheter.

In this answer

4 sections

01

Confirming the Cause and Assessing Risk

02

Catheter Options for Managing Retention

03

The Role of Medications and Bladder Testing

04

Choosing a Procedure to Relieve the Blockage

⚠️ URGENT SAFETY WARNING
If you are completely unable to urinate, have severe lower abdominal pain or swelling, fever, chills, flank (lower back) pain, vomiting, confusion, heavy bleeding with clots, or if your catheter stops draining urine, seek emergency medical care immediately. Do not wait for a routine appointment.

If you are experiencing recurrent urinary retention (repeatedly being unable to empty your bladder), it is a strong reason for a prompt discussion with a urologist. While a temporary catheter can drain the bladder, recurrent retention usually indicates that a procedure to relieve the physical blockage is needed [1][2]. However, the decision is highly individualized based on the exact cause, your kidney and bladder health, surgical risks, and your personal goals.

Confirming the Cause and Assessing Risk

Before discussing long-term management, your doctor must confirm that your retention is actually caused by benign prostatic hyperplasia (BPH) and not by something else, such as a urinary tract infection, bladder stones, medications, a urethral stricture, or a neurologic condition [3].

Your evaluation will typically include a review of your history and medications, a physical exam, a urinalysis, and tests to check your kidney function and the amount of urine left in your bladder (postvoid residual) [3].

Guidelines generally recommend discussing surgery to remove the prostate blockage if your retention is accompanied by “high-risk” complications attributable to BPH [2][1]:

  • Recurrent urinary tract infections (UTIs): Stagnant urine breeds bacteria [1].
  • Bladder stones: Minerals in leftover urine can crystallize [1].
  • Gross hematuria: Visible blood in the urine, which always requires its own thorough evaluation to rule out other causes like malignancy [4][3].
  • Hydronephrosis or renal insufficiency: The backup of urine causes the kidneys to swell (hydronephrosis) and can reduce kidney function (renal insufficiency) [2][1].

Catheter Options for Managing Retention

When you go into urinary retention, immediate catheterization is needed to decompress the bladder. Afterward, your doctor may suggest a “Trial Without Catheter” (TWOC) to see if you can pee on your own. If you still cannot empty your bladder, or if you are awaiting surgery, you will need ongoing drainage. A catheter drains urine, but it does not fix the underlying blockage.

  • Clean intermittent catheterization (CIC): This involves inserting a thin tube to empty your bladder and immediately removing it, multiple times a day [5]. It is often the preferred method because it carries lower risks of symptomatic infection and provides a better quality of life compared to a permanent catheter [6][7]. However, it requires training by a clinician, a set schedule, and manual dexterity. Because of the enlarged prostate, passing the catheter can sometimes be difficult and carries risks of urethral trauma or bleeding [8].
  • Indwelling urethral catheter (Foley): This tube stays in your urethra continuously and drains into a bag. It is typically used for the shortest clinically appropriate time [5]. Prolonged use increases the risk of symptomatic urinary tract infections, urethral damage, and restrictions on your daily activities [6][9]. Note that simply having bacteria in the urine (colonization) is common with a Foley, but symptomatic infections require medical treatment.
  • Suprapubic catheter: A doctor surgically places this tube directly into your bladder through a small incision in your lower abdomen [10]. It is considered when long-term drainage is needed. It may improve comfort and avoid urethral injuries, but it is not risk-free [11][5]. Placement carries surgical and anesthesia risks, and long-term use still carries risks of blockages, leakage, skin problems, and bladder stones [12].

The Role of Medications and Bladder Testing

Medications

  • Alpha-blockers (e.g., tamsulosin, alfuzosin): Often prescribed to relax the prostate and bladder neck, improving the chance of a successful Trial Without Catheter [13][5]. Side effects can include dizziness, low blood pressure when standing, and falls.
  • 5-alpha-reductase inhibitors (e.g., finasteride): These shrink the prostate over months to reduce the risk of future retention, but they do not fix an immediate blockage [14][15]. They are used only for sufficiently enlarged prostates, can cause sexual side effects, and alter PSA test results.
  • Note: Review all your medications with your doctor, as some over-the-counter and prescription drugs can actually worsen retention.

Bladder Function Testing (Urodynamics)

Urodynamics are selective tests that evaluate how well your bladder stores and releases urine [16]. They are not required for every patient but are useful if the diagnosis is uncertain or if your doctor suspects your bladder muscle has become too weak to squeeze effectively (detrusor underactivity or an acontractile bladder) [17][18].

If your bladder muscle is weak, relieving the prostate obstruction through surgery can still help, but recovery may be incomplete [19][20]. You must be prepared for the possibility that you might still need to use a catheter temporarily or long-term after surgery [21].

Choosing a Procedure to Relieve the Blockage

The goal of a procedure is to open the urinary channel. The choice depends on your prostate size, anatomy, overall health, and personal goals [22][23].

  • Prostate Size and Anatomy: Transurethral Resection of the Prostate (TURP) is common for moderately enlarged prostates [24]. For larger prostates, or for men in retention, laser enucleation (HoLEP) is highly effective [25][26]. Your doctor will also check for a median lobe (prostate tissue growing up into the bladder), which affects which procedures will work [27].
  • Minimally Invasive Options: Procedures like UroLift, Rezūm, and Aquablation offer different ways to open the channel [24][28]. However, they have specific size and anatomy requirements, and their evidence and suitability for men with recurrent retention varies (as many pivotal trials excluded men in retention). They are not automatically interchangeable with more definitive surgeries for treating severe blockage [29].
  • Health and Bleeding Risk: If you take blood thinners, vaporization procedures (like GreenLight) or HoLEP may be considered because of their bleeding profiles [24][30]. Important safety warning: Never stop or change your blood thinners without direct instructions from both the prescribing clinician and your urologist. No procedure eliminates bleeding risk entirely.

General Surgical Risks and Recovery

Any prostate procedure carries risks. These commonly include temporary postoperative catheterization, burning or urgency during urination, bleeding, infection, and a small risk of urethral stricture (scarring) or urinary incontinence. There is also a chance you may need retreatment in the future.

Regarding sexual function, definitive surgeries like TURP and HoLEP carry a high risk of retrograde ejaculation (semen enters the bladder instead of exiting the penis during climax) [31][28]. This is not the same as erectile dysfunction (loss of erection), but it means little or no semen comes out, which is important if preserving fertility or normal ejaculation is a priority for you.

Common questions in this guide

What is the usual treatment for recurrent urinary retention from BPH?
A catheter is usually used first to drain the bladder, followed by an evaluation to confirm that BPH is causing the blockage. An alpha-blocker may improve the chance of urinating after catheter removal, but repeated retention often leads to discussion of a procedure that opens the prostate channel. The best option depends on prostate size, bladder and kidney function, other health conditions, and personal goals.
Which procedures can relieve a BPH blockage when retention keeps coming back?
Options may include transurethral resection of the prostate (TURP), laser enucleation (HoLEP), GreenLight vaporization, Aquablation, UroLift, or Rezūm. TURP and HoLEP are established ways to remove or open obstructing prostate tissue, while minimally invasive treatments have specific size and anatomy requirements and may have less evidence in people with recurrent retention. A urologist can match the procedure to your prostate anatomy, health, bleeding risk, and goals.
Can medicine prevent recurrent urinary retention from BPH?
Alpha-blockers such as tamsulosin or alfuzosin relax the prostate and bladder neck and may improve the chance of passing a catheter-removal trial. Finasteride and other 5-alpha-reductase inhibitors can shrink a sufficiently enlarged prostate over several months and lower future retention risk, but they do not relieve an immediate blockage. These medicines can have side effects and should be chosen with a clinician.
What catheter choices are available if I cannot empty my bladder?
Clean intermittent catheterization involves inserting and removing a tube several times a day and often has lower infection risk and less impact on daily life than a permanent tube when it can be done safely. A Foley catheter stays in the urethra and drains into a bag, while a suprapubic catheter enters the bladder through the lower abdomen for longer-term drainage. Each option has risks, and intermittent catheterization requires training and enough hand function to perform it safely.
Could I still need a catheter after BPH surgery?
Yes. If the bladder muscle has become weak, opening the prostate may not fully restore bladder emptying, so catheter use may be temporary or long term. Your urologist may use bladder-function testing when the diagnosis is uncertain or weak bladder contraction is suspected.
When is urinary retention an emergency?
Seek emergency care if you cannot urinate, have severe lower abdominal pain or swelling, fever or chills, flank pain, vomiting, confusion, heavy bleeding or clots, or a catheter that stops draining. Do not wait for a routine appointment because untreated blockage can harm the bladder or kidneys.

Related questions

Do Alpha-Blockers Cause Ejaculation or Erection Problems? How Do Tamsulosin, Alfuzosin, and Silodosin Compare? Which Medications Worsen Urinary Symptoms in Men With BPH? How Can Dizziness from BPH Alpha-Blockers Be Managed Safely? When Are Cystoscopy and Urodynamic Studies Needed for BPH?
Show more
Does Saw Palmetto Work for BPH? Evidence and Safety When Is a Trial Without Catheter Done After BPH-Related Retention? What Causes Nocturia with BPH and How Can You Reduce It? Can Diet and Exercise Shrink the Prostate with BPH? Is Blood in the Urine from BPH? Hematuria Evaluation Can BPH Raise PSA? When High PSA Needs Further Evaluation Is a Prostate MRI or Biopsy Needed for BPH Diagnosis? What Do Uroflowmetry and PVR Tests Show in Men With BPH? Can BPH Cause Recurrent UTIs or Bladder Stones? Next Steps Can Untreated BPH Cause Bladder or Kidney Damage Over Time? How Often Should BPH Follow-Up Visits and Tests Occur? Will My Prostate Keep Growing? BPH Retention and Surgery Risk What Symptoms and Measurements to Track for BPH Evaluation? Does BPH Raise Prostate Cancer Risk? How to Tell Them Apart

Get notified when new evidence is published on prostatic adenoma.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (31)
  1. 1

    Management of Benign Prostatic Hyperplasia.

    Kim EH, Larson JA, Andriole GL

    Annual review of medicine 2016; (67()):137-51 doi:10.1146/annurev-med-063014-123902.

    PMID: 26331999
  2. 2

    AUA White Paper on Nonneurogenic Chronic Urinary Retention: Consensus Definition, Treatment Algorithm, and Outcome End Points.

    Stoffel JT, Peterson AC, Sandhu JS, et al.

    The Journal of urology 2017; (198(1)):153-160 doi:10.1016/j.juro.2017.01.075.

    PMID: 28163030
  3. 3

    Which investigations should be performed after a first episode of urinary tract infection in men?

    Soudais B, Bruyère F, Forestier E, et al.

    Infectious diseases now 2026; (56(6S)):105315 doi:10.1016/j.idnow.2026.105315.

    PMID: 42323088
  4. 4

    Medical and Surgical Treatment Modalities for Lower Urinary Tract Symptoms in the Male Patient Secondary to Benign Prostatic Hyperplasia: A Review.

    Macey MR, Raynor MC

    Seminars in interventional radiology 2016; (33(3)):217-23 doi:10.1055/s-0036-1586142.

    PMID: 27582609
  5. 5

    Management of acute urinary retention in men with benign prostatic hyperplasia: Literature review and guidelines from the French Urological Association Male LUTS Panel (CTMH).

    Pinar U, Gas J, Sarrazin C, et al.

    The French journal of urology 2025; (35(11)):102953 doi:10.1016/j.fjurol.2025.102953.

    PMID: 41271374
  6. 6

    Impact of clean intermittent self-catheterization and indwelling catheterization on perioperative outcomes in patients with urinary retention undergoing BPH surgery: A comparative monocentric retrospective study.

    Denimal L, Klein C, Capon G, et al.

    The French journal of urology 2025; (35(1)):102851 doi:10.1016/j.fjurol.2024.102851.

    PMID: 39710328
  7. 7

    The Patient Pathway for Men with Chronic Urinary Retention: Treatments, Complications, and Consequences.

    Bos BJ, van Merode NAM, Steffens MG, Witte LPW

    Urology 2022; (167()):185-190 doi:10.1016/j.urology.2022.03.036.

    PMID: 35489523
  8. 8

    The role of clean intermittent catheterization in rehabilitation setting: a survey of healthcare operators' perception in Italy.

    Risi O, De Palma L, Andretta E

    European journal of physical and rehabilitation medicine 2020; (56(4)):525-528 doi:10.23736/S1973-9087.20.06171-7.

    PMID: 32301597
  9. 9

    A Multicenter Study of Patient-Reported Infectious and Noninfectious Complications Associated With Indwelling Urethral Catheters.

    Saint S, Trautner BW, Fowler KE, et al.

    JAMA internal medicine 2018; (178(8)):1078-1085 doi:10.1001/jamainternmed.2018.2417.

    PMID: 29971436
  10. 10

    Urinary Catheter Management.

    Fletke KJ, Jeong DH, Herrera AV

    American family physician 2024; (110(3)):251-258.

    PMID: 39283848
  11. 11

    Urethral (indwelling or intermittent) or suprapubic routes for short-term catheterisation in hospitalised adults.

    Kidd EA, Stewart F, Kassis NC, et al.

    The Cochrane database of systematic reviews 2015; CD004203 doi:10.1002/14651858.CD004203.pub3.

    PMID: 26661940
  12. 12

    Update on voiding dysfunction managed with suprapubic catheterization.

    English SF

    Translational andrology and urology 2017; (6(Suppl 2)):S180-S185 doi:10.21037/tau.2017.04.16.

    PMID: 28791237
  13. 13

    Comparing effects of alpha-blocker management on acute urinary retention secondary to benign prostatic hyperplasia: A systematic review and network meta-analysis.

    Gwon YN, Park JJ, Yang WJ, et al.

    Prostate international 2023; (11(2)):91-99 doi:10.1016/j.prnil.2022.12.002.

    PMID: 37409094
  14. 14

    Non-interventional and medical management of lower urinary tract symptoms related to benign prostatic hyperplasia in men: Guidelines of the French LUTS Committee (CTMH).

    Anract J, Klein C, Sarrazin C, et al.

    The French journal of urology 2025; (35(11)):102952 doi:10.1016/j.fjurol.2025.102952.

    PMID: 41271371
  15. 15

    5 Alpha Reductase Inhibitors (5ARIs) Monotherapy and Combinations: Current Role in Benign Prostatic Hyperplasia (BPH) Management.

    Roidos C, Sountoulides P, Papathanasiou K, et al.

    Medicina (Kaunas, Lithuania) 2026; (62(5)) doi:10.3390/medicina62050975.

    PMID: 42195228
  16. 16

    Lower Urinary Tract Symptoms in Men: A Review.

    Wei JT, Dauw CA, Brodsky CN

    JAMA 2025; (334(9)):809-821 doi:10.1001/jama.2025.7045.

    PMID: 40658396
  17. 17

    Non-neurogenic Chronic Urinary Retention: What Are We Treating?

    Stoffel JT

    Current urology reports 2017; (18(9)):74 doi:10.1007/s11934-017-0719-2.

    PMID: 28730405
  18. 18

    Summary Paper on Underactive Bladder from the European Association of Urology Guidelines on Non-neurogenic Male Lower Urinary Tract Symptoms.

    Baboudjian M, Hashim H, Bhatt N, et al.

    European urology 2024; (86(3)):213-220 doi:10.1016/j.eururo.2024.04.004.

    PMID: 38644139
  19. 19

    Clinical outcomes of benign prostatic hyperplasia surgery in men with detrusor underactivity versus normal contractility: a systematic review and meta-analysis.

    Calvillo-Ramirez A, Esparza-Miranda LA, Casas-Huesca AP, et al.

    International urology and nephrology 2026; (58(10)):4015-4025 doi:10.1007/s11255-026-05188-z.

    PMID: 42115505
  20. 20

    Efficacy of Holmium Laser Enucleation of the Prostate in Patients With Detrusor Underactivity or Acontractile Bladder.

    Choi S, Lee JH, Yu J, et al.

    International neurourology journal 2025; (29(2)):118-124 doi:10.5213/inj.2550020.010.

    PMID: 40635421
  21. 21

    Long-term Efficacy of Holmium Laser Enucleation of the Prostate in Patients With Detrusor Underactivity or Acontractility.

    Lomas DJ, Krambeck AE

    Urology 2016; (97()):208-211 doi:10.1016/j.urology.2016.07.010.

    PMID: 27450935
  22. 22

    [Operative treatment of benign prostatic hyperplasia for the elderly].

    Tomkalski W, Suława A, Fedorowicz SA

    Medycyna pracy 2025; (76(3)):217-222 doi:10.13075/mp.5893.01635.

    PMID: 40607692
  23. 23

    Treatment Algorithm for Management of Benign Prostatic Obstruction: An Overview of Current Techniques.

    Hughes T, Harper P, Somani BK

    Life (Basel, Switzerland) 2023; (13(10)) doi:10.3390/life13102077.

    PMID: 37895457
  24. 24

    Surgical and interventional management of bladder outlet obstruction related to benign prostatic hyperplasia: Systematic review of the literature and Clinical Practice Guidelines from the French Male LUTS Committee (CTMH).

    Klein C, Anract J, Pinar U, et al.

    The French journal of urology 2025; (35(11)):102951 doi:10.1016/j.fjurol.2025.102951.

    PMID: 41271373
  25. 25

    Holmium laser enucleation of the prostate (HoLEP): a review and update.

    Das AK, Teplitsky S, Humphreys MR

    The Canadian journal of urology 2019; (26(4 Suppl 1)):13-19.

    PMID: 31481144
  26. 26

    Comparison of holmium laser enucleation and transurethral resection of prostate in benign prostatic hyperplasia: a systematic review and meta-analysis.

    Chen F, Chen Y, Zou Y, et al.

    The Journal of international medical research 2023; (51(8)):3000605231190763 doi:10.1177/03000605231190763.

    PMID: 37561537
  27. 27

    The median lobe scenario. How to tackle this challenge best: systematic review and expert guidance.

    Alghamlas A, Zekraoui O, Herrmann TRW, et al.

    World journal of urology 2026; (44(1)):114 doi:10.1007/s00345-025-06172-5.

    PMID: 41554936
  28. 28

    Minimally Invasive Treatments for Benign Prostatic Obstruction: A Systematic Review and Network Meta-analysis.

    Cornu JN, Zantek P, Burtt G, et al.

    European urology 2023; (83(6)):534-547 doi:10.1016/j.eururo.2023.02.028.

    PMID: 36964042
  29. 29

    Five-year Retreatment and Medication Restart Rates Following Benign Prostate Hyperplasia Treatments: A Nationwide Real-world Analysis Using Epic Cosmos.

    Carletti F, Tamborino F, Turcan A, et al.

    European urology focus 2026; (12(3)):383-392 doi:10.1016/j.euf.2026.01.003.

    PMID: 41558957
  30. 30

    Is Holmium Laser Enucleation of the Prostate a Good Surgical Alternative in Benign Prostatic Hyperplasia Management? A Review Article.

    Abedi A, Razzaghi MR, Rahavian A, et al.

    Journal of lasers in medical sciences 2020; (11(2)):197-203 doi:10.34172/jlms.2020.33.

    PMID: 32273963
  31. 31

    Holmium laser enucleation of the prostate: patient selection and perspectives.

    Marien T, Kadihasanoglu M, Miller NL

    Research and reports in urology 2016; (8()):181-192 doi:10.2147/RRU.S100245.

    PMID: 27800470

This page is for informational purposes only and does not constitute medical advice. A urologist should assess your recurrent urinary retention, kidney and bladder health, medications, and urgent symptoms before treatment decisions.